(Q34614720)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997071%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

review article

1 reference

title

Nutraceuticals and prostate cancer prevention: a current review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997071%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997071%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Greg Trottier

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997071%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Peter J Boström

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997071%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Neil E Fleshner

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997071%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

language of work or name

English

0 references

publication date

8 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997071%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

published in

Nature Reviews Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997071%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997071%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997071%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

21-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997071%20AND%20SRC:MED&resulttype=core&format=json

Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County

14 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Nutraceutical-definition and introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

A prospective study of tomato products, lycopene, and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Lycopene: a novel drug therapy in hormone refractory metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Effects of soy protein isolate consumption on prostate cancer biomarkers in men with HGPIN, ASAP, and low-grade prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Lycopene and soy isoflavones in the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Rationale for statins in the chemoprevention of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Pharmacological approaches to reducing the risk of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Chemoprevention of prostate cancer: what can be recommended to patients?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Vitamin D and the epidemiology of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Geographic trends in prostate cancer mortality: an application of spatial smoothers and the need for adjustment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

UV, latitude, and spatial trends in prostate cancer mortality: All sunlight is not the same (United States)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Age-adjusted mortality rate and regional distribution for prostatic carcinoma in Italy between 1969 and 1978

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Residential sunlight exposure is associated with a decreased risk of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Serum vitamin D metabolite levels and the subsequent development of prostate cancer (Hawaii, United States)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Serum vitamin D concentration and prostate cancer risk: a nested case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Vitamin D and cancer mini-symposium: the risk of additional vitamin D.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Vitamin D for cancer prevention: global perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

31 March 2020

The promiscuous receptor

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Supplemental and dietary vitamin E intakes and risk of prostate cancer in a large prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Prostate Cancer and Supplementation With α-Tocopherol and β-Carotene: Incidence and Mortality in a Controlled Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Lycopene as the most efficient biological carotenoid singlet oxygen quencher

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Lycopene: modes of action to promote prostate health

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Cohort study of diet, lifestyle, and prostate cancer in Adventist men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Intake of carotenoids and retinol in relation to risk of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Lycopene is more bioavailable from tomato paste than from fresh tomatoes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

A prospective study of lycopene and tomato product intake and risk of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

The U.S. Food and Drug Administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Lycopene for advanced hormone refractory prostate cancer: a prospective, open phase II pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Soy, isoflavones, and prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Soy protein isolate increases urinary estrogens and the ratio of 2:16alpha-hydroxyestrone in men at high risk of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

The specific role of isoflavones in reducing prostate cancer risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Soy isoflavones in the treatment of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Anti-oxidants from green tea and pomegranate for chemoprevention of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Dietary agents for chemoprevention of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Green tea consumption and prostate cancer risk in Japanese men: a prospective study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

A prospective study of diet and prostate cancer in Japanese men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Protective effect of green tea against prostate cancer: A case‐control study in southeast China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

A case-control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Randomized trials of antioxidant supplementation for cancer prevention: first bias, now chance--next, cause

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Observational versus randomised trial evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Intensive lifestyle changes may affect the progression of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Dietary intervention in prostate cancer patients: PSA response in a randomized double-blind placebo-controlled study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.234

Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis

31 March 2020

1 reference

12 December 2020

Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.

1 reference

12 December 2020

Evaluation of vitamin D analogs as therapeutic agents for prostate cancer

1 reference

12 December 2020

A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii

1 reference

12 December 2020

Soy isoflavones do not modulate prostate-specific antigen concentrations in older men in a randomized controlled trial.

1 reference

12 December 2020

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

1 reference

12 December 2020

Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States

1 reference

12 December 2020

Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy

1 reference

12 December 2020

Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.

1 reference

12 December 2020

Vitamin D and prostate cancer: a prediagnostic study with stored sera.

1 reference

12 December 2020

Circulating vitamin D metabolites in relation to subsequent development of prostate cancer

1 reference

12 December 2020

Minimal effect of a low-fat/high soy diet for asymptomatic, hormonally naive prostate cancer patients.

1 reference

12 December 2020

Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).

1 reference

12 December 2020

Alternative medicine use in patients with localized prostate carcinoma treated with curative intent

1 reference

12 December 2020

Vitamin E supplements and risk of prostate cancer in U.S. men.

1 reference

12 December 2020

Response of hormone refractory prostate cancer to lycopene

1 reference

12 December 2020

Mediterranean diet and cancer

1 reference

12 December 2020

The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2009.234

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19997071%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

14 February 2020

1031528696

0 references

1 reference